More about

Atherosclerotic Cardiovascular Disease

News
October 17, 2021
3 min read
Save

Coronary calcium serves as ‘iceberg in the water’ when evaluating ASCVD risk

Coronary calcium serves as ‘iceberg in the water’ when evaluating ASCVD risk

Although various studies have established the prognostic value of coronary artery calcium scoring for predicting atherosclerotic risk, some current models do not take coronary calcium into account, a speaker reported.

News
October 05, 2021
2 min read
Save

CVD, risk factor prevalence greater in Black vs. white Americans

CVD, risk factor prevalence greater in Black vs. white Americans

Over 20 years, CVD risk and CV risk factor prevalence was greater in Black Americans compared with white Americans, though the difference may have been mediated by social determinants of health, researchers reported.

News
September 30, 2021
2 min read
Save

Assessment of Lp(a) role in all atherogenic lipoproteins possible with existing assays

Assessment of Lp(a) role in all atherogenic lipoproteins possible with existing assays

Utilizing commercially available assays, researchers demonstrated the feasibility of evaluating the specific atherogenic contributions of lipoprotein(a) in cholesterol at the National Lipid Association Scientific Sessions.

News
September 16, 2021
1 min read
Save

Premature menopause associated with increased ASCVD risk

Premature menopause associated with increased ASCVD risk

Premature menopause was associated with an increased risk for atherosclerotic CVD, according to new findings published in JAMA Cardiology.

News
September 13, 2021
2 min read
Save

Target young women with migraine for increased cardiovascular risk prevention

Target young women with migraine for increased cardiovascular risk prevention

Women with migraine headaches should receive targeted atherosclerotic cardiovascular disease prevention, including attention to safer contraception and safe menopausal hormone therapy, beginning in young adulthood, according to a speaker.

News
August 30, 2021
3 min read
Save

CV safety of prostate cancer therapies ‘remains unresolved’: PRONOUNCE

CV safety of prostate cancer therapies ‘remains unresolved’: PRONOUNCE

In the PRONOUNCE trial, which aimed to compare the CV safety of androgen deprivation therapies for prostate cancer, there was no difference in major adverse CV events at 1 year among adults with prostate cancer and atherosclerotic CVD.

News
August 05, 2021
2 min read
Save

Coronary artery calcium presence associated with ASCVD events

Coronary artery calcium presence associated with ASCVD events

The presence of coronary artery calcium among individuals with risk-enhancing factors was associated with increased atherosclerotic CVD events, exceeding the threshold for statin therapy initiation, researchers reported.

News
July 30, 2021
2 min read
Save

Combining multiple novel therapies for secondary prevention may lower event risk in ASCVD

Combining multiple novel therapies for secondary prevention may lower event risk in ASCVD

The combination of icosapent ethyl, ezetimibe and rivaroxaban may lower risk for CV death, MI and stroke well beyond the treatment effect of secondary prevention with background medical therapy for atherosclerotic CVD, a speaker reported.

News
July 26, 2021
2 min read
Save

MINOCA not benign, should be treated as a syndrome

MINOCA not benign, should be treated as a syndrome

Patients with MI or ischemia without obstructive CAD are at elevated risk for poor CV outcomes and doctors need to pinpoint the cause of ischemia, according to a speaker.

News
July 25, 2021
2 min read
Save

Algorithm developed for managing suspected ACS in patients hospitalized with COVID-19

Algorithm developed for managing suspected ACS in patients hospitalized with COVID-19

Diagnosis of ACS in concomitant COVID-19 infection can be made difficult due to an overlap of symptoms, fewer patients presenting to the hospital and a lack of guidance diagnosing hospitalized patients, a speaker reported.

View more